EU4Health call for tenders to support the uptake of biosimilars in a multistakeholder approach

HaDEA has published a call for tenders HADEA/2023/OP/0040 - Capacity building to support the uptake of biosimilars in a multistakeholder approach.

Biosimilar medicines have a similar efficacy and safety compared with their reference medicines and hold the potential to achieve significant savings for health systems and improve access to medicines for patients. Still, barriers remain and, to a certain extent, impede their successful entry into the market and uptake by health systems.

This call for tenders aims to support national authorities in implementing policies and practices that improve biosimilar competition to contribute to the accessibility, affordability and availability of medicines for patients in the EU.

Estimated budget: €1 500 000

Check out the call documents and apply on the Funding & Tenders portal. 

All interested parties are invited to send in their applications by 9 February 2024, 16:00 (CET).

Background

EU4Health, with a budget of €5.3 billion, is the fourth and largest of the EU health programmes. The EU4Health programme goes beyond an ambitious response to the COVID-19 crisis to address the resilience of European healthcare systems. The programme provides funding to national authorities, health organisations and other bodies through grants and public procurement, contributing to a healthier Europe.

HaDEA manages the vast majority of the total EU4Health budget and implements the programme by managing calls for proposals and tenders from 2021 to 2027.